When Does the Mounjaro Price Increase Take Effect in the UK?

What official guidance tells us about how Mounjaro is priced and why it changed

Mounjaro (tirzepatide) holds a UK marketing authorisation for weight management in adults, confirmed by the MHRA and assessed by NICE in Technology Appraisal 1026, published in December 2024. That regulatory backdrop matters here because it shapes how private market pricing works: Eli Lilly, as the manufacturer, sets the list price from which private pharmacies and clinics work, and the September 2025 uplift was Lilly's first significant UK list-price revision since the medicine launched in this market.

Before the change, the highest-dose pen carried a list price of around £122 per four-week supply. After 1 September 2025, that figure moved to around £330, a steep increase, widely reported at the time and confirmed by Lilly UK, and if you want to understand the timeline of how those increases have been structured, our guide on when Mounjaro prices go up is worth reading before you plan your next order. Lower doses carry lower list prices, so the impact varies depending on where you are in the titration schedule. The 5mg price increase details how mid-range doses were affected specifically, and the starter-dose picture is worth reading if you're earlier in treatment.

Private providers set their own retail prices above the list price to cover clinical costs, operational costs and support infrastructure. So while the list-price movement sets a floor, what you actually pay depends on what the provider wraps around the medicine, and those extras vary considerably between services.

What headline prices often leave out, and why that gap matters

A price quoted for Mounjaro in isolation can be misleading. Some services show the lowest available dose as a headline figure, which may not reflect what you'd pay at the dose your prescriber recommends after assessment. Others quote the pen cost and bill separately for the consultation, the prescription, delivery and any follow-up support.

Run those extras up and the gap between a stripped-back advertised price and the actual cost of a properly supervised treatment course can be meaningful. This isn't a minor admin detail, clinical oversight between doses, a prescriber who reviews your progress before each repeat and a direct line to aftercare support are the parts of treatment that protect you if something feels off. They're also the parts most easily left off a comparison table.

The Mounjaro private pricing guide covers what a realistic all-in cost looks like, and if you want to understand why the September increase happened in the first place, the reasons behind the price change are worth a read before making any decisions.

Where nume stands on price, and what that single figure covers

nume is not the cheapest option. That's a deliberate position, not an oversight. One transparent price covers the consultation, the prescription written by a GPhC-registered Independent Prescriber, the treatment itself, and free next-working-day DPD delivery, tracked, in plain packaging, with nothing hidden at checkout. There are no subscriptions, no automatic renewals and no separately billed clinical fees. Order before 12pm on a weekday and, once your prescriber confirms clinical suitability, your treatment goes out the same day, useful if you're working around a busy afternoon or the school run.

Every repeat order is individually re-reviewed by a prescriber before it's approved. That matters after a price change, too: you aren't locked into a billing cycle that adjusts automatically. You can see the current treatment pricing on the weight-loss treatments page, and our about page explains the clinical governance behind how we operate.

Why cheapest is the wrong question to ask about a prescription medicine

There's a pattern worth naming plainly. When a high-profile list-price increase hits the news, some buyers go looking for the lowest available price, and some sellers respond to that demand in ways that carry real risk. The MHRA has warned repeatedly about fake tirzepatide pens sold online, including the October 2025 raid on a Northampton site producing counterfeit Mounjaro. Fake pens have been found to contain insulin; the consequences of injecting the wrong substance can be serious.

A prescription medicine should be assessed by the question: is this service legitimate, clinically supervised and operating through the licensed UK supply chain? You can check any online pharmacy against the GPhC register at pharmacyregulation.org, nume's registration number is 9012878. Prices far below the market rate, offers without a clinical assessment, or discount codes attached to prescription medicines are all reasons to look elsewhere. For more on the safety picture around where and how to access tirzepatide, tirzepatide pricing context covers the broader landscape.

The September 2025 increase changed what Mounjaro costs. It didn't change what good clinical care looks like. If you'd like to see whether treatment is appropriate for you, check your eligibility with a free consultation, a real prescriber reviews your answers the same day.